109
Views
5
CrossRef citations to date
0
Altmetric
Abstracts

THE EFFECTS OF HEMODILUTION ON ACUTE INFLAMMATORY RESPONSES IN A BLEOMYCIN-INDUCED LUNG INJURY MODEL

, , , , , , , , , , & show all
Pages 841-857 | Received 20 Feb 2009, Accepted 03 Apr 2009, Published online: 08 Dec 2009

REFERENCES

  • Monk TG: Acute normovolemic hemodilution. Anesthesiol Clin N Am. 2005;23:271–281.
  • Jones SB, Whitten CW, Monk TG: Influence of crystalloid and colloid replacement solutions on hemodynamic variables during acute normovolemic hemodilution. J Clin Anesth. 2004;16:11– 17.
  • Jones SB, Whitten CW, Despotis GJ, Monk TG: The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg. 2003;96:363–368.
  • Claes Y, Van Hemelrijck J, Van Gerven M, Arnout J, Vermylen J, Weidler B, Van Aken H: Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg. 1992;75:24–30.
  • Jamnicki M, Kocian R, Van Der Linden P, Zaugg M, Spahn DR: Acute normovolemic hemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth. 2003;17:747–754.
  • Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334– 1349.
  • Elias JA, Freundlich B, Kern JA, Rosenbloom J: Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990;97:1439–1345.
  • King RJ, Jones MB, Minoo P: Regulation of lung cell proliferation by polypeptide growth factors. Am J Physiol. 1989;257:L23–L38.
  • Stark RA, Nahrwold ML, Cohen PJ: Blind oral tracheal intubation of rats. J Appl Physiol. 1981;51:1355–1356.
  • Gross JB: Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983;58:277– 2780.
  • Pearce FJ, Waasdorp C, Hufnagel H, Burris D, DeFeo J, Soballe P, Drucker WR: Subcutaneous PO2 as an index of the physiological limits for hemodilution in the rat. J Appl Physiol. 2005;99:814– 821.
  • Ashcroft T, Simpson JM, Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467–470.
  • Morita Y, Chin-Yee I, Yu P, Sibbald WJ, Martin CM: Critical oxygen delivery in conscious septic rats under stagnant or anemic hypoxia. Am J Respir Crit Care Med. 2003;167:868–872.
  • Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA: Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217–221.
  • Weiskopf RB, Feiner J, Hopf HW, Viele MK, Watson JJ, Kramer JH, Ho R, Toy P: Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002;96:871–877.
  • Van Bommel J, Siegemund M, Henny CP, Van Den Heuvel DA, Trouwborst A, Ince C: Preservation of intestinal microvascular PO2 during normovolemic hemodilution in a rat model. J Lab Clin Med. 2000;135:476–483.
  • Margarido CB, Margarido NF, Otsuki DA, Fantoni DT, Marumo CK, Kitahara FR, Magalhães AA, Pasqualucci CA, Auler JO Jr: Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution. Shock 2007;27:390–396.
  • Licker M, Mariethoz E, Costa MJ, Morel D: Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion. Crit Care Med. 2005;33:2302–2308.
  • Homi HM, Yang H, Pearlstein RD, Grocott HP: Hemodilution during cardiopulmonary bypass increases cerebral infarct volume after middle cerebral artery occlusion in rats. Anesth Analg. 2004;99(10):974–981.
  • Bishop MJ, Cheney FW: The effects of hemodilution during pulmonary edema in dogs. Ann Surg. 1983;198:96–101.
  • Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R: Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol. 2002;83:111–119.
  • Karmouty-Quintana H, Cannet C, Zurbruegg S, Blé FX, Fozard JR, Page CP, Beckmann N: Bleomycin-induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J Magn Reson Imaging 2007;26:941–949.
  • Dik WA, McAnulty RJ, Versnel MA, Naber BA, Zimmermann LJ, Laurent GJ, Mutsaers SE: Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats. Thorax. 2003;58:765–771.
  • Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001;7:1–7.
  • Strieter RM, Kunkel SL: Acute lung injury. the role of cytokines in the elicitation of neutrophils. J Invest Med. 1994;42:640–651.
  • Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 1999;160:961–967.
  • Rinaldo JE, Christman JW: Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med. 1990;11:621–632.
  • Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995;108:1303–1314.
  • Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:602–611.
  • Opal SM, Cross AS: Clinical trials for severe sepsis. Past failures, and future hopes. Infect Dis Clin North Am. 1999;13:285–297.
  • Ferro TJ, Hocking DC, Johnson A: Tumor necrosis factor-alpha alters pulmonary vasoreactivity via neutrophil-derived oxidants. Am J Physiol. 1993;265:L462–L471.
  • Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 1996;153:1850–1856.
  • Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, Suzuki R: Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:43–46.
  • Siler TM, Swierkosz JE, Hyers TM, Fowler AA, Webster RO: Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res. 1989;15:881–894.
  • Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016–1022.
  • Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, White NJ, Griffin GE: Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun. 1992;60:2402–2408.
  • Donnelly TJ, Meade P, Jagels M, Cryer HG, Law MM, Hugli TE, Shoemaker WC, Abraham E: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med. 1994;22:768–776.
  • Parsons PE, Moore FA, Moore EE, Iklé DN, Henson PM, Worthen GS: Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis. 1992;146:694–700.
  • Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18:428–432.
  • Chaudhary NI, Schnapp A, Park JE: Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173:769–776.
  • Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J: Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol. 1994;10:148–153.
  • Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, Nelson S: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 1994;149:1107–1111.
  • Tran Van Nhieu J, Misset B, Lebargy F, Carlet J, Bernaudin JF: Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;147:1585–1589.
  • Jacobs RF, Tabor DR, Burks AW, Campbell GD: Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis. 1989;140:1686–1692.
  • Jules-Elysee KM, Stover DE, Zaman MB, Bernard EM, White DA: Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med. 1990;112:750–757.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.